Gannett Co., Inc. (NYSE:GCI – Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $3.96 and last traded at $3.87, with a volume of 1478340 shares trading hands. The stock had previously closed at $3.76. Analysts Set New Price Targets Separately, Citigroup raised […]
Gannett Co., Inc. (NYSE:GCI – Get Free Report) shares hit a new 52-week high on Monday . The stock traded as high as $3.96 and last traded at $3.87, with a volume of 1478340 shares trading hands. The stock had previously closed at $3.76. Analysts Set New Price Targets Separately, Citigroup raised Gannett from a […]
Calidi Biotherapeutics, Inc. (NYSEAMERICAN:CLDI – Get Free Report) shares were down 35% during trading on Friday . The company traded as low as $0.19 and last traded at $0.19. Approximately 5,675,219 shares were traded during mid-day trading, an increase of 1,254% from the average daily volume of 419,281 shares. The stock had previously closed at […]
Calidi Biotherapeutics, Inc. (NYSEAMERICAN:CLDI – Get Free Report) was the recipient of a large increase in short interest during the month of May. As of May 15th, there was short interest totalling 295,100 shares, an increase of 547.1% from the April 30th total of 45,600 shares. Based on an average trading volume of 937,700 shares, […]
Palmer Square Capital BDC Inc. (NYSE:PSBD – Get Free Report) has received an average recommendation of “Moderate Buy” from the seven analysts that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price […]